TECVAYLI
A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma
Near Add Your Location
Sorting 13 by
- Accepting patients
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
- Not currently accepting
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
- Accepting patients
Mayo Clinic (Jacksonville)
Jacksonville, FL
- Accepting patients
- Accepting patients
- Accepting patients
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.